Posts
March 13 2024
ESGEN Acquisition Corp., a publicly-traded special purpose acquisition company, announced the completion of its business combination with Sunergy Renewables, LLC, a leading Florida-based provider of residential solar and energy efficiency solutions. At the closing, ESGEN changed its name to “Zeo Energy Corp.” and will be led by Sunergy’s senior management. The transaction is valued at approximately $18,000,000. EGS acted as counsel to Sunergy Renewables, LLC.
March 12 2024
Client Alert: New York City Publishes Workers’ Bill of Rights
Late last year, New York City enacted a law requiring all employers to provide their employees with a “Worker’s Bill of Rights.” Earlier this month, the New York Department of Consumer and Worker Protection published the “Workers’ Bill of Rights” to be posted and distributed. The poster contains a QR code, which refers employees to the full Workers’ Bill of Rights.
Click here to read the alert.
March 11 2024 Event
Webinar: Recent Trends in Union Activity
Join the Labor & Employment Lawyers from Ellenoff Grossman & Schole LLP for a complimentary webinar on the current state of union activity and implications for employers. Recently, it seems you can’t avoid the headlines regarding union activity – from union elections to an active National Labor Relations Board supporting these efforts. New developments are coming out weekly and are impacting industries that have been traditionally spared this focus. All employers need to be aware of how to navigate this landscape.
Click here to register.
March 11 2024
EGS is proud to announce that partners Barry Grossman and Matthew Gray were recognized by MergerLinks in their Top DeSPAC Lawyers in North America list for 2023. Congrats to Barry and Matt!
Click here to see the rankings.
March 10 2024
Danimer Scientific, Inc. announced the closing of its Registered Direct offering in the amount of $15,000,000. EG&S acted as counsel to the Placement Agent.
March 09 2024
ASLAN Pharmaceuticals Limited announced the closing of its Registered Direct offering in the amount of $5,000,000. EG&S acted as counsel to the Placement Agent.
March 08 2024
Vivani Medical, Inc., an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, announced the pricing of its registered direct offering in the amount of $15,000,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent in connection with the offering.
March 08 2024
Cadrenal Therapeutics, Inc. announced the commencement of its At The Market Offering in the amount of $5,143,730. EG&S acted as counsel to the Sales Agent.